SeaCrest Wealth Management’s Avanos Medical AVNS Stock Holding History

SeaCrest Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,099	Closed	-$47K	–	618
2019 Q1	$47K	Buy	1,099 +207	+23%	+$9.27K	0.01%	959
2018 Q4	$40K	Sell	892 -156	-15%	-$8.17K	0.01%	972
2018 Q3	$72K	Buy	+1,048	New	+$67.4K	0.01%	867
2018 Q2	–	Sell	-1,602	Closed	-$74K	–	2198
2018 Q1	$74K	Hold	1,602	–	–	0.01%	801
2017 Q4	$74K	Buy	+1,602	New	+$73.6K	0.01%	816

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SeaCrest Wealth Management's AVNS Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 1,099 shares — an estimated $47K sold.

SeaCrest Wealth Management first reported a position in AVNS in Q4 2017 and held it in 5 quarters. The position peaked at $74K in Q1 2018. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

SeaCrest Wealth Management reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 1,099 Avanos Medical shares in Q2 2019, an estimated $47K.
SeaCrest Wealth Management first reported a position in Avanos Medical in Q4 2017 and held it in 5 quarters.
SeaCrest Wealth Management's Avanos Medical position peaked at $74K in Q1 2018.
317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.